There's a new DNA test for babies that can check for 193 genetic diseases

Forget counting fingers and toes — new parents may soon be able to analyze their baby's genes.
MIT Technology Review reported Wednesday that the health information company Sema4 has developed a DNA test that screens babies for almost 200 genetic diseases. The test, which costs $649, is intended to expand on existing screeners recommended by the U.S. government, which only flag roughly 30 genetic disorders. With the ability to identify a greater number of abnormalities in their baby's first days — including ones that otherwise may not yield accurate diagnoses for years — parents can "get a better understanding of the health of your child," said Eric Schadt, the CEO of Sema4.
The test uses saliva procured from a baby's cheek to screen for problematic genetic alterations, as well as potential reactions to a range of medications usually given to young children, the Review says. Sema4's test has not yet been approved for coverage by insurance companies, which means dutiful parents will have to pick up the tab on their own for the time being.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The potential for expanded health knowledge isn't without its consequences. Some of the genetic abnormalities Sema4 is designed to detect may not cause symptoms for years, the Review notes, and "sometimes a child can carry a mutation but never develop the corresponding disease" at all. That means that overanxious parents may subject their children to expensive or intrusive medical procedures based on Sema4's results that may not actually be necessary. Laura Hercher, a genetics professor at Sarah Lawrence College, cautioned: "For many families, this is the kind of thing that can open up a can of worms where it doesn't end up necessarily benefiting the parent or child."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kelly O'Meara Morales is a staff writer at The Week. He graduated from Sarah Lawrence College and studied Middle Eastern history and nonfiction writing amongst other esoteric subjects. When not compulsively checking Twitter, he writes and records music, subsists on tacos, and watches basketball.
-
Trump's China tariffs start after Canada, Mexico pauses
Speed Read The president paused his tariffs on America's closest neighbors after speaking to their leaders, but his import tax on Chinese goods has taken effect
By Peter Weber, The Week US Published
-
Chinese AI chatbot's rise slams US tech stocks
Speed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
By Peter Weber, The Week US Published
-
US port strike averted with tentative labor deal
Speed Read The strike could have shut down major ports from Texas to Maine
By Peter Weber, The Week US Published
-
Biden expected to block Japanese bid for US Steel
Speed Read The president is blocking the $14 billion acquisition of U.S. Steel by Japan's Nippon Steel, citing national security concerns
By Peter Weber, The Week US Published
-
Judges block $25B Kroger-Albertsons merger
Speed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
By Peter Weber, The Week US Published
-
Rupert Murdoch loses 'Succession' court battle
Speed Read Murdoch wanted to give full control of his empire to son Lachlan, ensuring Fox News' right-wing editorial slant
By Peter Weber, The Week US Published
-
Bitcoin surges above $100k in post-election rally
Speed Read Investors are betting that the incoming Trump administration will embrace crypto
By Peter Weber, The Week US Published
-
Enron mystery: 'sick joke' or serious revival?
Speed Read 23 years after its bankruptcy filing, the Texas energy firm has announced its resurrection
By Peter Weber, The Week US Published